Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2026-03-01 @ 1:27 PM
Study NCT ID:
NCT03268057
Status:
COMPLETED
Last Update Posted:
2022-05-02
First Post:
2017-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Sponsor:
Vaccinex Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-10
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-11
First Submit QC Date:
None
Study First Post Date:
2017-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-25
Last Update Post Date:
2022-05-02
Last Update Post Date Type:
ACTUAL